158 related articles for article (PubMed ID: 19436333)
1. Immunoregulatory role of TNFalpha in inflammatory kidney diseases.
Ernandez T; Mayadas TN
Kidney Int; 2009 Aug; 76(3):262-76. PubMed ID: 19436333
[TBL] [Abstract][Full Text] [Related]
2. Soluble cytokine receptors in renal vasculitis and lupus nephritis.
Tesar V; Jirsa M; Zima T; Kalousová M; Bartunková J; Stejskalová A; Dostál C; Zabka J
Med Sci Monit; 2002 Jan; 8(1):BR24-9. PubMed ID: 11782670
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 2 activation by bacterial peptidoglycan-associated lipoprotein activates cardiomyocyte inflammation and contractile dysfunction.
Zhu X; Bagchi A; Zhao H; Kirschning CJ; Hajjar RJ; Chao W; Hellman J; Schmidt U
Crit Care Med; 2007 Mar; 35(3):886-92. PubMed ID: 17255871
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for tumor necrosis factor blockade with the therapeutic antibody golimumab.
Ono M; Horita S; Sato Y; Nomura Y; Iwata S; Nomura N
Protein Sci; 2018 Jun; 27(6):1038-1046. PubMed ID: 29575262
[TBL] [Abstract][Full Text] [Related]
5. Distinct role of tumor necrosis factor receptor subtypes 1 and 2 in the red nucleus in the development of neuropathic pain.
Zeng XY; Zhang Q; Wang J; Yu J; Han SP; Wang JY
Neurosci Lett; 2014 May; 569():43-8. PubMed ID: 24686175
[TBL] [Abstract][Full Text] [Related]
6. Targeting Tumor Necrosis Factor Receptor 1 with Selected Aptamers for Anti-Inflammatory Activity.
Chu X; Du X; Yang L; Wang Z; Zhang Y; Wang X; Dai L; Zhang J; Liu J; Zhang N; Zhao Y; Gu H
ACS Appl Mater Interfaces; 2023 Mar; 15(9):11599-11608. PubMed ID: 36812453
[TBL] [Abstract][Full Text] [Related]
7. Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis.
Stokes MB; Foster K; Markowitz GS; Ebrahimi F; Hines W; Kaufman D; Moore B; Wolde D; D'Agati VD
Nephrol Dial Transplant; 2005 Jul; 20(7):1400-6. PubMed ID: 15840673
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor receptor cross-talk.
Naudé PJ; den Boer JA; Luiten PG; Eisel UL
FEBS J; 2011 Apr; 278(6):888-98. PubMed ID: 21232019
[TBL] [Abstract][Full Text] [Related]
9. Functions of TNF and its receptors in renal disease: distinct roles in inflammatory tissue injury and immune regulation.
Vielhauer V; Mayadas TN
Semin Nephrol; 2007 May; 27(3):286-308. PubMed ID: 17533007
[TBL] [Abstract][Full Text] [Related]
10. TNFα/TNFR2 signaling pathway: an active immune checkpoint for mesenchymal stem cell immunoregulatory function.
Beldi G; Khosravi M; Abdelgawad ME; Salomon BL; Uzan G; Haouas H; Naserian S
Stem Cell Res Ther; 2020 Jul; 11(1):281. PubMed ID: 32669116
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor (TNF) receptor type 1 (p55) is a main mediator for TNF-alpha-induced skin inflammation.
Kondo S; Sauder DN
Eur J Immunol; 1997 Jul; 27(7):1713-8. PubMed ID: 9247582
[TBL] [Abstract][Full Text] [Related]
12. Evoked pain behavior and spinal glia activation is dependent on tumor necrosis factor receptor 1 and 2 in a mouse model of bone cancer pain.
Geis C; Graulich M; Wissmann A; Hagenacker T; Thomale J; Sommer C; Schäfers M
Neuroscience; 2010 Aug; 169(1):463-74. PubMed ID: 20417692
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor receptor-associated factor-1 enhances proinflammatory TNF receptor-2 signaling and modifies TNFR1-TNFR2 cooperation.
Wicovsky A; Henkler F; Salzmann S; Scheurich P; Kneitz C; Wajant H
Oncogene; 2009 Apr; 28(15):1769-81. PubMed ID: 19287455
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor‑α in systemic lupus erythematosus: Structure, function and therapeutic implications (Review).
Ghorbaninezhad F; Leone P; Alemohammad H; Najafzadeh B; Nourbakhsh NS; Prete M; Malerba E; Saeedi H; Tabrizi NJ; Racanelli V; Baradaran B
Int J Mol Med; 2022 Apr; 49(4):. PubMed ID: 35137914
[TBL] [Abstract][Full Text] [Related]
15. B7.2 on activated and phagocytic microglia in the facial axotomy model: regulation by interleukin-1 receptor type 1, tumor necrosis factor receptors 1 and 2 and endotoxin.
Bohatschek M; Kloss CU; Pfeffer K; Bluethmann H; Raivich G
J Neuroimmunol; 2004 Nov; 156(1-2):132-45. PubMed ID: 15465604
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-α signaling in macrophages.
Parameswaran N; Patial S
Crit Rev Eukaryot Gene Expr; 2010; 20(2):87-103. PubMed ID: 21133840
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor receptors: biology and therapeutic potential in kidney diseases.
Speeckaert MM; Speeckaert R; Laute M; Vanholder R; Delanghe JR
Am J Nephrol; 2012; 36(3):261-70. PubMed ID: 22965073
[TBL] [Abstract][Full Text] [Related]
18. TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure.
Ramesh G; Reeves WB
Am J Physiol Renal Physiol; 2003 Oct; 285(4):F610-8. PubMed ID: 12865254
[TBL] [Abstract][Full Text] [Related]
19. Superoxide anion-induced pain and inflammation depends on TNFα/TNFR1 signaling in mice.
Yamacita-Borin FY; Zarpelon AC; Pinho-Ribeiro FA; Fattori V; Alves-Filho JC; Cunha FQ; Cunha TM; Casagrande R; Verri WA
Neurosci Lett; 2015 Sep; 605():53-8. PubMed ID: 26291484
[TBL] [Abstract][Full Text] [Related]
20. Lysyl oxidase (LOX) down-regulation by TNFalpha: a new mechanism underlying TNFalpha-induced endothelial dysfunction.
Rodríguez C; Alcudia JF; Martínez-González J; Raposo B; Navarro MA; Badimon L
Atherosclerosis; 2008 Feb; 196(2):558-64. PubMed ID: 17673218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
